Helius Medical reports preliminary Q4 revenue $275-285K; FY2022 revenue up ~50% YoY

Solana Co

2022-FY EPS reported -$1.04 revenue$787,000

Q4 2022 revenue projected $275K-$285K, sequential increase of ~40% over Q3 2022.
FY2022 revenue projected $780K-$790K, ~50% increase over FY2021.
Unaudited year-end cash balance $14.5M, down from $16.7M at September 30.
Launched UpScript Telehealth e-commerce site for PoNS therapy; initial shipments in Jan 2023.
Online PT training module launched July 2022, reducing training time to 3 hours or less.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Solana Co reported full year ended December 31, 2022 results: revenue $780,000 to $790,000.

Period: full year ended December 31, 2022
Revenue: $780,000 to $790,000
Result: preliminary results

Exact text from the filing

Full year 2022 revenue projected to range from $780,000 to $790,000

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Solana Co reported quarter ended December 31, 2022 results: revenue $275,000 to $285,000.

Period: quarter ended December 31, 2022
Revenue: $275,000 to $285,000
Result: preliminary results

Exact text from the filing

Q4 2022 revenue projected to range from $275,000 to $285,000

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Solana Co filing history →

Source: SEC EDGAR

accession 0001558370-23-000410

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.